Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
133 hedge funds and large institutions have $1.26B invested in Portola Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 19 reducing their positions, and 12 closing their positions.
225% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 12
168% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 19
68% more call options, than puts
Call options by funds: $962K | Put options by funds: $572K
34% more capital invested
Capital invested by funds: $939M → $1.26B (+$322M)
23% more funds holding
Funds holding: 108 → 133 (+25)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$44.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$28.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$19.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.12M |
| 2 |
JP Morgan Chase
New York
|
-$4.32M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.04M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$3.79M |
| 5 |
Millennium Management
New York
|
-$3.17M |
PTLA Hedge Fund Activity: Q4 2014 in Review
133 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q4 2014, worth a combined $1.26B — up 34% from $939M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new PTLA positions and 12 closed out — a net gain of 27 holders — while 51 added to existing stakes and 19 trimmed.
The largest buyer was Temasek Holdings, adding an estimated $44.5M. The largest seller was Sectoral Asset Management, cutting an estimated $8.12M.
- 133 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q4 2014, up from 108 in Q3 2014.
- Funds reported $1.26B of Portola Pharmaceuticals, Inc. stock for Q4 2014, up 34% quarter-over-quarter.
- 39 funds opened new Portola Pharmaceuticals, Inc. positions in Q4 2014 and 12 closed out, a net change of +27 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q4 2014 was Temasek Holdings, an estimated $44.5M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q4 2014 was Sectoral Asset Management, an estimated $8.12M sold.
Based on aggregated 13F filings for Q4 2014.